{
      "datestamp": "2026-05-26 15:47:22",
      "rev_number": 1,
      "publisher": "\"Research Science and Innovation house\" LLC",
      "keywords": "Surunkali yurak yetishmovchiligi, qandli diabet, SGLT 2 ingibitori, renin angiotenzin sistemasi, miokard infarkti.",
      "dir": "disk0/00/05/48/70",
      "sword_depositor": 1,
      "lastmod": "2026-05-26 15:47:22",
      "publication": "Journal of Universal Science Research",
      "eprint_status": "archive",
      "title": "Surunkali yurak yetishmovchiligi bilan kasallangan kasallarni davolashda SGLT 2 ingibitorlarining roli.",
      "status_changed": "2026-05-26 15:47:22",
      "abstract": "Natriy-glyukoza ko-transporterlari-2 (SGLT2 ) surunkali yurak yetishmovchiligi bilan kasallangan bemorlarni davolashdagi nisbatan yangi guruh dori vositalaridan hisoblanadi. Bu guruh dori moddalariga empagliflozin, dapagliflozin, sotagliflozin, ertugliflozin kabi dori vositalari kiradi. Bu dori vositalarining asosiy ta\u2019sir mexanizmi buyrakning proksimal naychalaridan glyukoza so\u2019rilishini kamaytirish hisoblanadi. SGLT2 ingibitorlari gipoglikemik dori vosita sifatida 2-tip Qandli diabet bilan kasallangan bemorlarni davolashda qo\u2019llaniladi. Glyukoza so\u2019rilishini kamaytirish bilan birgalikda miokard infarkti, insult va yurak qon tomir kasalliklaridan o\u2019lim xavfini kamaytiradi. SGLT2 ingibitorlarining bir qancha ta\u2019sir mexanizmi aniqlangan bo\u2019lishiga qaramasdan aynan qanday mexanizm orqali yurak qon tomir kasalliklaridan o\u2019lim xavfini kamaytirishi no\u2019malumligicha qolmoqda. Biroq shu kungacha o\u2019tkazilgan tadqiqotlar shuni ko\u2019rsatmoqdaki SGLT2 ingibitorlari   surunkali yurak yetishmovchiligining barcha bosqichlarida 1 A ko\u2019rsatma sifatida qo\u2019llash mumkin.",
      "creators": [
        {
          "name": {
            "lineage": null,
            "family": "A.",
            "honourific": null,
            "given": "Murtozoyev E."
          }
        },
        {
          "name": {
            "given": "Jobborov O.",
            "honourific": null,
            "lineage": null,
            "family": "O."
          }
        },
        {
          "name": {
            "lineage": null,
            "family": "X.",
            "honourific": null,
            "given": "Maksudova M."
          }
        }
      ],
      "eprintid": 54870,
      "uri": "https://arxiv.universalpublishings.com/id/eprint/54870",
      "date": "2023-09-24",
      "type": "article",
      "full_text_status": "none",
      "id_number": "oai:ojs.pkp.sfu.ca:article/1999",
      "userid": 1,
      "official_url": "https://universalpublishings.com/index.php/jusr/article/view/1999",
      "subjects": [
        "Surunkali yurak yetishmovchiligi, qandli diabet, SGLT 2 ingibitori, renin angiotenzin sistemasi, miokard infarkti."
      ],
      "ispublished": "pub",
      "date_type": "published",
      "metadata_visibility": "show",
      "note": "Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/1999)"
    }